Winfield Associates’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-40
Closed -$5K 238
2017
Q4
$5K Buy
+40
New +$4.14K ﹤0.01% 512
2017
Q3
Sell
-35
Closed -$3K 808
2017
Q2
$3K Buy
+35
New +$3.08K ﹤0.01% 614
2016
Q4
Sell
-25
Closed -$2K 740
2016
Q3
$2K Buy
25
+10
+67% +$1K ﹤0.01% 529
2016
Q2
$2K Buy
15
+5
+50% +$516 ﹤0.01% 521
2016
Q1
$1K Buy
+10
New +$959 ﹤0.01% 566

Other funds holding CRI

Winfield Associates's CRI Position: Q1 2018 in Review

Winfield Associates sold out of Carter's (CRI) in Q1 2018, closing a stake of 40 shares — an estimated $5K sold.

Winfield Associates first reported a position in CRI in Q1 2016 and held it in 5 quarters. The position peaked at $5K in Q4 2017. 384 funds tracked by Wall St. Rank hold CRI as of Q1 2018.

  • Winfield Associates reported no remaining Carter's position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 40 Carter's shares in Q1 2018, an estimated $5K.
  • Winfield Associates first reported a position in Carter's in Q1 2016 and held it in 5 quarters.
  • Winfield Associates's Carter's position peaked at $5K in Q4 2017.
  • 384 funds tracked by Wall St. Rank held Carter's as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.